“Nextech offers a critical eye, both discerning and impactful, to our protein degradation approach, clinical development and partnering opportunities, and has done so since they began visiting us in New Haven years before investing. Their depth of knowledge and collaborative approach make Nextech an important partner for us.”
John G. Houston, Ph.D.
President and CEO
Arvinas, Inc.